Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

ClinicalTrials.gov ID: NCT00973362

Public ClinicalTrials.gov record NCT00973362. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of the APTIMA® HPV Assay on the TIGRIS® DTS® System in Women With ASC-US Pap Test Results and in Women 30 Years of Age or Older With Negative Pap Test Results Using ThinPrep Pap Test Specimens

Study identification

NCT ID
NCT00973362
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gen-Probe, Incorporated
Industry
Enrollment
12,896 participants

Conditions and interventions

Interventions

  • APTIMA HPV Assay Device
  • FDA-Approved HPV DNA Test Device

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2008
Primary completion
May 31, 2013
Completion
Mar 31, 2014
Last update posted
Jan 5, 2017

2008 – 2014

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
NEA Clinic Women's Clinic Jonesboro Arkansas 72401
San Fernando Valley Research Canoga Park California 91306
Healthcare Partners of Monterey Park Los Angeles California 90015
Diverse Research Solutions Oxnard California 93030
REMEK Pomona California 91767
West Coast OB-Gyn San Diego California 92123
HealthCare Partners Torrance California 90503
Penninsula Research Associates Torrance California 90505
Community Medical Research of South Florida Miami Florida 33141
Insignia Clinical Research Tampa Florida 33613
Emory University School of Medicine Atlanta Georgia 30303
Indiana Univ. School of Medicine Dept of Pathology Wishard Health Sciences Indianapolis Indiana 46202
Saginaw Valley Medical Research Saginaw Michigan 48604
PPS Clinical Chesterfield Missouri 63017
Planned Parenthood of Eastern Arkansas and Oklahoma Tulsa Oklahoma 74105
Temple University Hospital Philadelphia Pennsylvania 19140
Adams Patterson OB-GYN Memphis Tennessee 38120

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00973362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00973362 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →